Linda Holmström
Keine laufenden Positionen mehr
Profil
Linda Holmström worked as a Director-Investor Relations at Oncopeptides AB, Manager-Brand & Communications at Recipharm AB, and Senior Manager-Communications & IR at Swedish Orphan Biovitrum AB.
Ehemalige bekannte Positionen von Linda Holmström
| Unternehmen | Position | Ende |
|---|---|---|
| ONCOPEPTIDES AB | Investor Relations Contact | - |
| SWEDISH ORPHAN BIOVITRUM AB | Investor Relations Contact | - |
| RECIPHARM AB (PUBL) | Public Communications Contact | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ONCOPEPTIDES AB | Health Technology |
| SWEDISH ORPHAN BIOVITRUM AB | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Recipharm AB
 Recipharm AB BiotechnologyHealth Technology Recipharm AB engages in the manufacture of pharmaceuticals and contract development services for pharmaceutical companies. It operates through the following segments: Manufacturing Sterile and Inhalation (MFG-SI); Manufacturing Solids and Others (MFG-SO); Development and Technology (D&T); and Others and Eliminations. The MFG-SI segment includes manufacturing of products on behalf of pharmaceutical companies and covers sterile and inhalation technologies as well as liquid vials and ampoules, lyophilisates, blow-fill-seal products, and inhalation. The MFG-SO segment produces products on behalf of pharmaceutical companies and covers tablets, capsules, semi-solids, and non-sterile liquids. The D&T segment focuses on pharmaceutical development services. The company was founded by Lars Rickard Backsell and Thomas Bengt Eldered in 1995 and is headquartered in Stockholm, Sweden. | Health Technology |
